About Xeris Biopharma Holdings Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.xerispharma.com/
Frequently Asked Questions
What is the 52-week range for XERS?
The 52-week high is $11.33 and the 52-week low is $5.25.
What is the P/E ratio for XERS?
The P/E ratio data is currently unavailable.
What is the dividend yield for XERS?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 99.74%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -5.12%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 97.76.
Analyst Recommendation Trends
Wall Street analyst consensus for XERS over the last few months:
Latest XERS News
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHICAGO, October 02, 2026--Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports
Investing.com -- H Lundbeck (LON:0ND5) has expressed interest in a potential takeover of Chicago-based commercial-stage drugmaker Xeris Pharmaceuticals Inc (NASDAQ:XERS), according to people familiar with the matter cited by Bloomberg. The Danish pharmaceutical group has been working with financial advisers to explore an acquisition of the U.S. firm, though discussions remain preliminary and may not result in a formal transaction.
Xeris Biopharma Reportedly Draws Takeover Interest — But Firm Says It’s ‘Not For Sale’
According to a Bloomberg report, Danish company Lundbeck has been working with advisers to explore a potential takeover of Xeris.
Lundbeck Is Said To Express Interest In Buying Xeris Biopharma, Bloomberg Reports
- Bloomberg
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday
U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securitize, Lakefront and others also gained.
Xeris Biopharma Holdings, Inc. (XERS) Discusses XP-8121 Program Overview, Phase 3 Study Details and Commercial Strategy - Slideshow
2026-09-11. The following slide deck was published by Xeris Biopharma Holdings, Inc.
Leerink Partners Maintains Outperform on Xeris Biopharma Holdings, Raises Price Target to $16
Leerink Partners analyst Roanna Ruiz maintains Xeris Biopharma Holdings (NASDAQ:XERS) with a Outperform and raises the price target from $12 to $16.
Xeris Biopharma Holdings, Inc. (XERS) Discusses XP-8121 Program Overview, Phase 3 Study Details and Commercial Strategy Transcript
Xeris Biopharma Holdings, Inc. (XERS) Discusses XP-8121 Program Overview, Phase 3 Study Details and Commercial Strategy September 9, 2026 10:00 AM...
Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism
CHICAGO, September 09, 2026--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, will host an XP-8121 Program Overview today at 10 a.m. ET detailing a comprehensive clinical development strategy, including Cornerstone, its Phase 3 registrational study design, as well as the commercial opportunity for XP-8121, its investigational once-weekly s
Xeris Biopharma To Host XP‑8121 Program Overview Detailing Phase 3 Study And Commercial Opportunity; Topline Results Expected In Late 2028; FDA Approval And Launch Anticipated In 2030
Initiation of Phase 3 registrational study on track by year-end; topline results expected in late 2028; U.S. FDA approval and launch anticipated in 2030The Company expects XP-8121 peak net revenue potential of $1 to $3
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-28 | McCulloch Kevin | -25,000 | $10 | $250,000 |
| 2026-09-01 | McCulloch Kevin | -15,000 | $8.4872 | $127,308 |
| 2026-09-01 | Pieper Steven | -5,000 | $8.5 | $42,500 |
| 2026-09-01 | Hecht Beth | -16,666 | $8.4864 | $141,434 |
| 2026-08-12 | Pieper Steven | -5,000 | $8.5 | $42,500 |
| 2026-08-03 | McCulloch Kevin | -15,000 | $8.016 | $120,240 |
| 2026-08-03 | Hecht Beth | -16,666 | $8.0135 | $133,553 |
| 2026-08-01 | McCulloch Kevin | -21,918 | $8.08 | $177,097 |
| 2026-08-01 | Shannon John Patrick Jr | -36,645 | $8.08 | $296,092 |
| 2026-07-07 | Pieper Steven | -27,600 | $8.5245 | $235,276 |
| 2026-07-06 | Pieper Steven | -17,400 | $8.5 | $147,900 |
| 2026-07-01 | McCulloch Kevin | -90,000 | $8.0279 | $722,511 |
| 2026-07-01 | KREHER NERISSA | +37,910 | $8 | $303,280 |
| 2026-07-01 | KREHER NERISSA | +33,582 | - | - |
| 2026-07-01 | Hecht Beth | -16,666 | $8.0319 | $133,860 |
| 2026-06-04 | Brady James Aloysius | +32,996 | $6.15 | $202,925 |
| 2026-06-04 | Brady James Aloysius | +24,193 | - | - |
| 2026-06-04 | HALKUFF DAWN | +32,996 | $6.15 | $202,925 |
| 2026-06-04 | HALKUFF DAWN | +24,193 | - | - |
| 2026-06-04 | HALKUFF DAWN | -20,000 | $6.0943 | $121,886 |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE | +32,996 | $6.15 | $202,925 |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE | +24,193 | - | - |
| 2026-06-04 | BORMANN-KENNEDY BARBARA-JEAN ANNE | -16,000 | $6.0942 | $97,507 |
| 2026-06-04 | Kong Garheng | +32,996 | $6.15 | $202,925 |
| 2026-06-04 | Kong Garheng | +24,193 | - | - |
| 2026-06-04 | JOHNSON JOHN | +32,996 | $6.15 | $202,925 |
| 2026-06-04 | JOHNSON JOHN | +24,193 | - | - |
| 2026-06-04 | JOHNSON JOHN | -15,000 | $6.0948 | $91,422 |
| 2026-06-04 | PERSKY MARLA | +32,996 | $6.15 | $202,925 |
| 2026-06-04 | PERSKY MARLA | +24,193 | - | - |
| 2026-06-03 | PERSKY MARLA | -15,500 | $5.8989 | $91,433 |
| 2026-06-01 | Hecht Beth | -16,667 | $6.0588 | $100,982 |
| 2026-05-01 | Hecht Beth | -16,667 | $6.2282 | $103,805 |
| 2026-04-01 | Hecht Beth | -16,667 | $5.9914 | $99,859 |
| 2026-03-30 | Brady James Aloysius | -10,834 | $5.5414 | $60,036 |
| 2026-03-12 | McCulloch Kevin | -4 | $3.94 | $16 |
| 2026-03-12 | McCulloch Kevin | -48,894 | $4.09 | $199,976 |
| 2026-03-12 | McCulloch Kevin | +4 | $3.94 | $16 |
| 2026-03-12 | McCulloch Kevin | +48,894 | $4.09 | $199,976 |
| 2026-03-05 | Pieper Steven | -14,036 | - | - |
| 2026-03-05 | Pieper Steven | -27,891 | - | - |
| 2026-03-05 | Pieper Steven | +14,036 | $5.93 | $83,233 |
| 2026-03-05 | Pieper Steven | +27,891 | $4.09 | $114,074 |
| 2026-03-02 | Hecht Beth | -100 | $7.06 | $706 |
| 2026-03-02 | Hecht Beth | -16,567 | $6.2401 | $103,380 |
| 2026-02-24 | Nguyen Anh Tu | -29,300 | $6.88 | $201,584 |
| 2026-02-02 | Hecht Beth | -16,667 | $7.4487 | $124,147 |
| 2026-01-31 | McCulloch Kevin | -27,319 | $7.36 | $201,068 |
| 2026-01-31 | McCulloch Kevin | -30,289 | $7.36 | $222,927 |
| 2026-01-31 | McCulloch Kevin | -68,454 | $7.36 | $503,821 |
| 2026-01-31 | Pieper Steven | -27,319 | $7.36 | $201,068 |
| 2026-01-31 | Pieper Steven | -66,450 | $7.36 | $489,072 |
| 2026-01-31 | Pieper Steven | -111,765 | $7.36 | $822,590 |
| 2026-01-31 | Hecht Beth | -24,266 | $7.36 | $178,598 |
| 2026-01-31 | Hecht Beth | -46,914 | $7.36 | $345,287 |
| 2026-01-31 | Hecht Beth | -98,375 | $7.36 | $724,040 |
| 2026-01-31 | Shannon John Patrick Jr | -110,750 | $7.36 | $815,120 |
| 2026-01-31 | Shannon John Patrick Jr | -111,621 | $7.36 | $821,531 |
| 2026-01-31 | Shannon John Patrick Jr | -118,134 | $7.36 | $869,466 |
| 2026-01-30 | Nguyen Anh Tu | +162,162 | - | - |
| 2026-01-30 | Nguyen Anh Tu | +121,293 | - | - |
| 2026-01-30 | McCulloch Kevin | +225,225 | - | - |
| 2026-01-30 | McCulloch Kevin | +168,463 | - | - |
| 2026-01-30 | Pieper Steven | +207,207 | - | - |
| 2026-01-30 | Pieper Steven | +154,986 | - | - |
| 2026-01-30 | Hecht Beth | +162,162 | - | - |
| 2026-01-30 | Hecht Beth | +121,293 | - | - |
| 2026-01-30 | Shannon John Patrick Jr | +639,639 | - | - |
| 2026-01-30 | Shannon John Patrick Jr | +478,436 | - | - |
| 2026-01-08 | McCulloch Kevin | -15,000 | $8 | $120,000 |
| 2026-01-05 | Shannon John Patrick Jr | -2,900 | - | - |
| 2026-01-05 | Shannon John Patrick Jr | -25,136 | - | - |
| 2026-01-05 | Shannon John Patrick Jr | -64,265 | - | - |
| 2026-01-05 | Shannon John Patrick Jr | +2,900 | $3.94 | $11,426 |
| 2026-01-05 | Shannon John Patrick Jr | +25,136 | $1.55 | $38,961 |
| 2026-01-05 | Shannon John Patrick Jr | +64,265 | $1.55 | $99,611 |
| 2026-01-05 | Shannon John Patrick Jr | -24,907 | $7.0766 | $176,257 |
| 2026-01-02 | Hecht Beth | -16,667 | $7.4264 | $123,776 |
| 2025-12-19 | JOHNSON JOHN | -135,400 | $7.2158 | $977,019 |
| 2025-12-12 | BORMANN-KENNEDY BARBARA-JEAN ANNE | -15,000 | $7.0943 | $106,415 |
| 2025-12-01 | Hecht Beth | -16,667 | $7.0067 | $116,781 |
| 2025-11-14 | Shannon John Patrick Jr | -87,100 | - | - |
| 2025-11-14 | Shannon John Patrick Jr | +87,100 | $1.55 | $135,005 |
| 2025-11-13 | Shannon John Patrick Jr | -8,970 | - | - |
| 2025-11-13 | Shannon John Patrick Jr | -23,242 | $7.4607 | $173,402 |
| 2025-11-13 | Shannon John Patrick Jr | +8,970 | $1.55 | $13,904 |
| 2025-11-11 | Hecht Beth | -16,667 | $7.3976 | $123,296 |